Nomi 2.5 mg Nasal Spray is a fast-acting medication used for the acute treatment of migraine attacks, with or without aura, in adults and adolescents aged 12–17 years. It contains Zolmitriptan, a selective serotonin (5-HT) receptor agonist that targets 5-HT1B and 5-HT1D receptors. By stimulating these receptors, Nomi constricts dilated cranial blood vessels and inhibits the release of pro-inflammatory neuropeptides, effectively alleviating migraine symptoms such as headache, nausea, and sensitivity to light and sound. The nasal spray formulation allows for rapid absorption through the nasal mucosa, providing relief within minutes of administration